Germany’s BioNTech Settles With US Agency, UPenn Over COVID Vaccine Royalties

Share!

Insurance Journal - Dec 27, 2024

BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania over the payment of royalties related to its COVID-19 vaccine, the company said in filings. The German company, which partners …...

Read Full Article

Recommended Articles

Cessna Jet Tied to Nascar Driver Greg Biffle Crashes in North Carolina

Posted: Dec 19, 2025

Former Nascar driver Greg Biffle and his family are believed to have died when their Cessna Citation...

Son of Ponzi-Accused Georgia Building & Loan Founder Now an Insurance Agent

Posted: Dec 19, 2025

The former co-leader of a collapsed Georgia savings and loan, a lending firm that is now the subject...

People Moves: Marsh McLennan Appoints Mathews Digital Infrastructure Leader; Loop Hired to Lead AXA XL Media Liability

Posted: Dec 19, 2025

Marsh McLennan, headquartered in New York City, appointed Mike Mathews as global digital infrastruct...